Schostak M, Koenig F, Boegemann M, Goebell P, Hammerer P, Machtens S, Schwentner C, Thomas C, Von Amsberg G, Von Rundstedt FC, Heidenreich A (2018)
Publication Type: Journal article
Publication year: 2018
Book Volume: 57
Pages Range: 813-820
Journal Issue: 7
DOI: 10.1007/s00120-018-0680-9
In March 2017 the aEuroeAdvanced Prostate Cancer Consensus Conference' (APCCC) took place in St. Gallen (Switzerland). The APCCC-panelists are internationally well known experts. With the actual data in mind they discussed treatment options for patients with advanced prostate cancer in order to update the international APCCC-recommendations from the previous meeting in 2015. Recently these consensus recommendations have been published in "European Urology". A group of German experts discussed this year APCCC-votes during the meeting and the recommendations that were concluded from the votes from the German perspective. Reasons for an additional German discussion are country-specific variations that may have influenced the APCCC-votes und recommendations. Due to the concept of the APCCC-meeting the wording of the questions could not always be as necessary. One focus of this year consensus discussion was the treatment of metastatic castration-naive prostate cancer (mCNPC). There are new data which may also influence the therapeutic situation of patients with metastatic castration-resistant prostate cancer (mCRPC). Further points of discussion were the impact of new imaging procedures in the clinical setting as well as the treatment of oligometastatic prostate cancer.
APA:
Schostak, M., Koenig, F., Boegemann, M., Goebell, P., Hammerer, P., Machtens, S.,... Heidenreich, A. (2018). Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts. Urologe, 57(7), 813-820. https://doi.org/10.1007/s00120-018-0680-9
MLA:
Schostak, M., et al. "Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts." Urologe 57.7 (2018): 813-820.
BibTeX: Download